Table of Contents
Fibrates are a class of medications primarily used to treat hyperlipidemia, particularly elevated triglycerides and low HDL cholesterol levels. While effective, they can cause adverse effects and interact with other drugs, which healthcare providers must carefully consider.
Common Adverse Effects of Fibrates
Most patients tolerate fibrates well, but some may experience side effects. The most frequently reported adverse effects include gastrointestinal disturbances such as nausea, abdominal pain, and diarrhea. Additionally, muscle-related symptoms like myopathy and, rarely, rhabdomyolysis can occur, especially when combined with statins.
Other potential adverse effects include elevated liver enzymes, which may indicate liver stress or damage. Fibrates may also increase the risk of gallstone formation due to alterations in bile composition.
Serious Adverse Effects
While rare, serious adverse effects can include severe myopathy and rhabdomyolysis, particularly in patients with predisposing factors or when combined with certain medications. Liver toxicity, though uncommon, has also been reported.
Drug Interactions of Fibrates
Fibrates interact with several other medications, which can increase the risk of adverse effects or reduce therapeutic efficacy. Notably, they have significant interactions with:
- Statins: The combination increases the risk of myopathy and rhabdomyolysis. Careful monitoring and dose adjustments are necessary.
- Oral Anticoagulants: Fibrates can potentiate the effects of anticoagulants, increasing bleeding risk. Regular INR monitoring is recommended.
- Bile Acid Sequestrants: These can reduce the absorption of fibrates, diminishing their effectiveness.
- Cyclophosphamide and Other Hepatotoxic Drugs: Concurrent use may enhance liver toxicity.
Precautions and Recommendations
Patients on fibrates should be monitored regularly for liver function, muscle symptoms, and kidney function. It is essential to review all medications to avoid harmful interactions. Patients with pre-existing liver or kidney disease, gallbladder issues, or a history of myopathy should use fibrates cautiously or avoid them altogether.
Healthcare providers should educate patients about recognizing signs of adverse effects, such as unexplained muscle pain or weakness, jaundice, or unusual bleeding, and advise immediate medical attention if they occur.